Author

Chih-Jung Chang

University of Glasgow

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Alina ZorniD· 1 shared Bria O’Gorman· 1 shared Connor M. BlairiD· 1 shared Danny T. Huang· 1 shared Elka KyurkchievaiD· 1 shared George S. Baillie· 1 shared Gillian Lappin· 1 shared Helen WheadoniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alina ZornORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting MDM2 homodimer and heterodimer disruption with DRx-098D in TP53 wild-type and mutant cancer cells

Sean F Cooke, Thomas A. Wright, Gillian Lappin, Elka Kyurkchieva, Yuan Yan Sin, Jiayue Ling, Alina Zorn, Bria O’Gorman, William Banyard, Chih-Jung Chang, Helen Wheadon, Danny T. Huang, George S. Baillie, Connor M. Blair

This study shows DRx-098D, a peptide disrupting MDM2 dimerisation, effectively inhibits cancer cell growth in TP53 wild-type and mutant cell lines, outperforming Idasanutlin in TP53 null cells.

Molecular Therapy Oncology · Aug 6, 2025Peer-reviewedCancer Biology